Elevance Health earnings were $5.2B for the trailing 12 months ending Mar 31, 2026, with -8.4% growth year over year. The latest ELV earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.8B, up 222.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ELV reported annual earnings of $5.7B, with -5.3% growth.
ELV past earnings growth
How has ELV's earnings growth performed historically?
What were Elevance Health's earnings last quarter?
On ELV's earnings call on Invalid Date, Elevance Health (NYSE: ELV) reported Q1 2026 earnings per share (EPS) of $8.03, up 16.7% year over year. Total ELV earnings for the quarter were $1.76 billion. In the same quarter last year, Elevance Health's earnings per share (EPS) was $9.64.
As of the last Elevance Health earnings report, Elevance Health is currently profitable. Elevance Health's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $5.24 billion, a 11.39% decrease year over year.
What was ELV's earnings growth in the past year?
As of Elevance Health's earnings date in Invalid Date, Elevance Health's earnings has grown -8.37% year over year. This is 21.63 percentage points higher than the US Healthcare Plans industry earnings growth rate of -30.01%. ELV earnings in the past year totalled $5.24 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.